KalebYohayMD
Child Neurology • New York, NYProfessor of Neurology and Pediatrics (Clinical), NYU Langone Health
Dr. Yohay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
New York, NY 10065Phone+1 212-746-3278Fax+1 212-746-8137
Summary
- I am a Pediatric Neurologist who specializes in Neurofibromatosis and Schwannomatosis. I am Director of the NYU Langone Comprehensive Neurofibromatosis Center, and care for adults and children with Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
Education & Training
Johns Hopkins UniversityFellowship, Child Neurology, 1999 - 2002- Johns Hopkins UniversityResidency, Pediatrics, 1997 - 1999
University of Vermont College of MedicineClass of 1997
Certifications & Licensure
NY State Medical License 2006 - 2025
MD State Medical License 2002 - 2007- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Concentration and Activity of Lapatinib in Vestibular Schwannomas Start of enrollment: 2009 Jun 01
- Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 Start of enrollment: 2013 Jun 01
- A Phase II Trial of Poly-ICLC for Low-Grade Gliomas Start of enrollment: 2021 Dec 15
Roles: Contact
Publications & Presentations
PubMed
- 20 citationsEfficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models.Kaleb Yohay, Betty Tyler, Kyle D. Weaver, Andrea C. Pardo, Dan Gincel
Journal of Neurosurgery. 2014-04-01 - 88 citationsCare of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Douglas R. Stewart, Bruce R. Korf, Katherine L. Nathanson, David A. Stevenson, Kaleb Yohay
Genetics in Medicine. 2018-04-26 - 33 citationsMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag
Neuro-Oncology. 2022-11-02
Journal Articles
- Articles Disease Characteristics and Progression in Patients with Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease: An Observational Cohort StudyBarry Kosofsky, Kaleb Yohay, Ronald G Crystal, ScienceDirect
Press Mentions
Mom of 4 Who Is Covered in Thousands of Tumors Says 'Every Day Is a Battle'January 15th, 2020
Professional Memberships
- Member
- Child Neurology SocietyMember
- Professors of Child NeurologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
